Skip to main content
. 2024 Dec 30;21:101. doi: 10.1186/s12981-024-00693-6

Table 3.

Associations with week 26 CIN2 + 

Characteristic Univariate Analysis: OR (95% CI) of CIN2 +  p-value Multivariable Analysis: OR (95% CI) of CIN2 +  p-value
ART Use at screening 0.7 (0.2, 2.8) 0.638
CD4 < 500 cells/mm3 1.3 (0.4, 4.5) 0.696
HIV RNA ≥ LLQ 2.1 (0.7, 6.7) 0.201
Age < 20 years at first vaginal sex 6.9 (0.8, 57.9) 0.074
With > 1 lifetime vaginal sex partner 0.3 (0.1, 1.0) 0.046 0.3 (0.1, 0.8) 0.023
With ≥ 2 years (104 weeks) of ART at entry 0.8 (0.3, 2.6) 0.724
Week 26 Abbott HPV 16 3.0 (0.5, 17.3) 0.219
Week 26 Abbott HPV 18 N/A* N/A*
Week 26 Abbott Other hr-HPV 3.1 (0.8, 12.0) 0.109
Week 26 Abbott hr-HPV 5.8 (1.1, 30.6) 0.036 3.5 (1.0, 12.0) 0.044
Week 26 Less Often Condom Use during vaginal sex 0.9 (0.3, 3.0) 0.890
Week 26 Not using condom during last vaginal sex 1.6 (0.4, 6.3) 0.515
Week 26 With > 1 vaginal sex partner in last 6 months N/A* N/A*

*No OR (95% CI) and p-value provided due to convergence issues